Barleyigeigetotal
This blood test measures antibodies to barley and checks your total IgE level to help diagnose a barley allergy.
{"Detects specific IgE antibodies against barley protein","Measures total IgE to assess overall allergic tendency","Helps diagnose or rule out barley as the cause of allergic symptoms","Results are reported as positive or negative with numeric values","Sample is collected from a blood draw in a laboratory"}
Key facts at a glance
- LOINC
- 61273-9
- Short code
- BARLEY
- Synonyms
- Barley IgE/IgE total %
- Category
- chemistry
- Sample
- serum
- Container
- Serum separator tube (SST) - yellow top, or red top tube without anticoagulant
- Units
- N/A
- Ref low
- 0
- Ref high
- 0.35
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- ≥ 0 years
- Method
- Fluorescent Enzyme Immunoassay (FEIA) / ImmunoCAP
- CPT
- 86003
- SNOMED
- 39513007
- Specimen volume
- 1 mL serum (minimum 0.5 mL)
- Stability
- Serum stable at room temperature for 7 days; refrigerated (2-8°C) for 7 days; frozen (-20°C) for up to 1 year. Avoid repeated freeze-thaw cycles.
- Hemolysis max
- 500
- Lipemia max
- 1000
- Icterus max
- 500
- TAT
- 24–72 hours
- Order
- routine
What is this test?
The Barley IgE Ab/IgE total test is a laboratory blood test that checks whether your immune system reacts to barley. It measures two things: (1) specific IgE antibodies against barley protein, and (2) your total IgE level, which reflects your overall allergic tendency. When you have an allergy, your immune system produces IgE antibodies that recognize and attack specific allergens like barley proteins.
How is the test performed?
A healthcare professional will draw a small sample of blood from a vein in your arm. The blood sample is sent to a laboratory where it is analyzed to detect the presence and amount of barley-specific IgE antibodies and total IgE. No special preparation is needed before the test.
What do the results mean?
Results are typically reported as either positive or negative for barley-specific IgE. A positive result means IgE antibodies to barley were detected, suggesting you may have a barley allergy. The level (concentration) of IgE may indicate the strength of the allergic reaction. Total IgE levels can help assess whether you have an atopic (allergic) tendency. Your healthcare provider will interpret these results together with your symptoms and medical history.
Reference range
Total IgE: <100 kU/L (adults); Barley-specific IgE: Class 0 (<0.35 kU/L) = Negative, Class 1 (0.35-0.70) = Low, Class 2 (0.71-3.50) = Moderate, Class 3 (3.51-17.50) = High, Class 4 (17.51-50.00) = Very High, Class 5 (50.01-100.00) = Very High, Class 6 (>100.00) = Extremely HighN/A
No fasting required. Patients should inform their healthcare provider of any antihistamine or corticosteroid use, as these medications may affect IgE test results. Avoid recent allergen exposure when possible.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
◆Associated findings1
Frequently asked questions
Do I need to fast before this test?
Can this test tell me how severe my allergy is?
How long does it take to get results?
What foods contain barley that I should avoid if allergic?
Is this test safe for children?
Sources
- 1
- 2
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy